Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Mexico / NCT05315596
Enrolling by invitation Observational

Longitudinal Assessment of Pain-Related Patient-Reported Outcomes After Surgery

NCT05315596 · tracked via the Priya Life Science Mexico tracker
Phase
Observational
Started
2022-02-01
Last updated
2022-04-07

Condition(s) studied

Pain, PostoperativeAdultPain MeasurementFunctional StatusPain ManagementNeuralgiaAnalgesia

Study summary

Little is known about pain-related outcomes experienced by patients in the first few weeks after surgery, once they are discharged from hospital.

This study aims to characterize pain, pain-related interference, and early neuropathic pain in the sub-acute phase after surgery.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Adult 2. On the first post-operative day and back on the ward for at least 6 hours 3. Gives consent for assessment at 3-time points Exclusion Criteria: 1. The patient is unable to communicate 2. The patient is cognitively impaired 3. The patient is asleep 4. The patient is too ill or in too much pain and does not wish to be interviewed 5. The patient does not wish to fill in the outcomes questionnaire

Primary outcome measure(s)

Trial sites (16)

FacilityCityRegionStatus
Jena University Hospital Jena Germany
Hospital General de Chihuahua Salvador Zubirán Anchondo El Bajo Chihuahua
Hospital Aranda de La Parra (Leon Guanajuato) León Guanajuato
Hospital Central Militar Mexico City Mexico City
Hospital San Javier Guadalajara Guadalajara Mexico
Centro Nacional SIGLO XXI (IMSS) Mexico City Mexico
Hospital Angeles Interlomas CDMX Mexico City Mexico
Hospital de traumatologia y Ortopedia Lomas Verdes (IMSS) Mexico City Mexico
Hospital fundación Medica Sur Mexico City Mexico
Hospital General de Villacoapa (IMSS) Mexico City Mexico
Hospital Ruben Leñero Mexico City Mexico
Instituto Nacional de Cancerología Mexico City Mexico
Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán Mexico City Mexico
Instituto Nacional de Enfermedades Respiratorias Cosio Villegas (INER) Mexico City Mexico
Hospital Angeles Puebla Puebla City Mexico
Hospital Central Morones Prieto San Luis Potosi San Luis Potosí City Mexico
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05315596 on ClinicalTrials.gov ↗ ← All trials in Mexico